Vasculitis: all 231 studies
Page 1 of 3. Open to participants first (69), then studies with results posted, then the rest; newest registration first within each.
- Benralizumab Effectiveness in EGPARecruitingNCT07815886
- Pain-Sleep in Rheumatic DiseaseNot yet recruitingNCT07775612Not applicable
- Ocular Manifestations of Granulomatosis With Polyangiitis.RecruitingNCT07664709
- Evaluate the Effectiveness and Safety of BBD-1 Multi-target Immune Enhancement Targeting Agent in the Treatment of Hypersensitivity Reaction (IgA) VasculitisRecruitingNCT07595367Phase 2
- SysteMic vAsculitis pRognosis and ouTcomeRecruitingNCT07586137
- Role of Vessel Wall MRI in Differentiaition Between Intracranial Atherosclerotic Disease and Vasculitis as Causes of Ischemic StrokeNot yet recruitingNCT07448454Not applicable
- Generative AI Impact on Rheumatoid Arthritis Complications DiagnosisRecruitingNCT07301892
- The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic ConditionsRecruitingNCT07278609
- Mapping B-cell Biology Across the Cardiovascular Territories of Giant Cell Arteritis: Towards a New Therapeutic Approach (RituxiMAP GCA)Not yet recruitingNCT07269938
- PET Assessment of Disease Activity and Cardiovascular Disease Risk in ANCA-associated VasculitisRecruitingNCT07258524
- Mass Spectrometry-based Immune Profiling in Autoimmune DiseasesEnrolling by invitationNCT07188285
- Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated VasculitisRecruitingNCT07160608Phase 2
- Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyRecruitingNCT07138898Phase 2
- Cardiac Imaging in Systemic Disorders: the ORACLES RegistryNot yet recruitingNCT07134166
- Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAVNot yet recruitingNCT06986018Early Phase 1
- Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)RecruitingNCT06983821Phase 3
- A Study of OL-108 in Relapsed/Refractory Autoimmune DiseasesRecruitingNCT06980597Phase 1
- UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune DiseasesNot yet recruitingNCT06978738Phase 1
- Pragmatic, Open-Label Study to Pilot Evaluation for Clinical Trials in Relapsing PolychondritisRecruitingNCT06941376Phase 2
- Prediction of Risk of Vascular Structural Damage in Patients with Large Vessel Vasculitis (LVV) Based on PET/MRA Image Evaluation SystemRecruitingNCT06824714
- Early-access Avacopan in Real-world ANCA-associated VasculitisRecruitingNCT06794827
- BCMA-CD19 CAR-T Therapy for Refractory Autoimmune DiseasesRecruitingNCT06794008Phase 2
- Characterization of "Bamboo" and Other Vocal Cord Lesions Responsible for Dysphonia in Patients With Systemic Autoimmune Diseases (BAMBOO)RecruitingNCT06779799
- MEMRI and Kidney DiseaseRecruitingNCT06698614
- AYLo - AutoimmunitY and Loss of yRecruitingNCT06696027
- Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune DiseasesRecruitingNCT06685042Phase 1/2
- Rare AutoImmune SElf-management Programme DevelopmentRecruitingNCT06642870
- Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated VasculitisRecruitingNCT06611696Phase 4
- ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUSRecruitingNCT06593041
- Anti-CD 19 CAR-T Cell Therapy in Patients With ANCA VasculitisNot yet recruitingNCT06590545Phase 1/2
- Neutrophil Extracellular Traps in Different Forms of Systemic SclerosisRecruitingNCT06462768
- Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune DiseaseRecruitingNCT06373081Not applicable
- Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)RecruitingNCT06350110Phase 1/2
- Intraoperative Application of Fluorescein Sodium Angiography in Vascular RetinopathyNot yet recruitingNCT06343961Not applicable
- Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune DiseasesRecruitingNCT06316076Phase 1
- Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T CellsRecruitingNCT06277427Not applicable
- Clonal Hematopoiesis in Giant Cell ArteritisNot yet recruitingNCT06244069
- Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)Not yet recruitingNCT06226662Phase 2
- National Registry of Rare Kidney DiseasesRecruitingNCT06065852
- Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune DiseaseRecruitingNCT06056921Phase 1
- Stratified Therapy on Pediatric AAGNRecruitingNCT05969522Phase 4
- Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)RecruitingNCT05965284Phase 4
- Efficacy and Safety for Rituximab Combined With Telitacicept in the Treatment of ANCA-associated Vasculitis (TTCAAVREM)RecruitingNCT05962840Phase 4
- A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO TrialRecruitingNCT05946564Phase 3
- Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory DiseasesRecruitingNCT05904301
- Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune DiseasesEnrolling by invitationNCT05859997Not applicable
- Longitudinal Study for Central Nervous System VasculitisRecruitingNCT05734404
- Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesRecruitingNCT05635266
- Vascular Lab Resource (VLR) BiorepositoryRecruitingNCT05628948
- Search for BIO Diagnostic and Prognostic Markers in Adult VAScularitisRecruitingNCT05565885
- Biomarkers in Autoimmune Diseases, Vasculitis and Auto Inflammatory DiseasesRecruitingNCT05383339
- Multicenter Cohort Study of AAV in Hunan of ChinaRecruitingNCT05315141
- Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune DiseasesRecruitingNCT05251415
- Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)RecruitingNCT05017142
- Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic SettingRecruitingNCT05012033
- Longitudinal Study for Relapsing PolychondritisRecruitingNCT04919538
- Efficacy and Safety of Belimumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Compared to Placebo. TRIBECA STUDY (Treatment nd BElimumab in Cryoglobulinemia Associated Vasculitis)RecruitingNCT04629144Phase 2
- Abatacept for the Treatment of Giant Cell ArteritisRecruitingNCT04474847Phase 3
- Prospective Longitudinal Cohort Study of Vasculitis PatientsRecruitingNCT04413331
- JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint InhibitorsRecruitingNCT04294771
- Whole Exome Sequencing of Familial and Pediatric Forms of VasculitisRecruitingNCT04006535
- Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid Arthritis, Vasculitis or Pulmonary SarcoidosisEnrolling by invitationNCT03755245Not applicable
- Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.RecruitingNCT03290456Not applicable
- Clinical Transcriptomics in Systemic Vasculitis (CUTIS)RecruitingNCT03004326
- Infliximab Therapy for Dolichoectactic Vertebrobasilar AneurysmsRecruitingNCT02638701Phase 1/2
- Vasculitis Pregnancy RegistryRecruitingNCT02593565
- A Real-World Registry of Chronic Wounds and UlcersRecruitingNCT02280733
- Pediatric Vasculitis InitiativeRecruitingNCT02006134
- One-Time DNA Study for VasculitisRecruitingNCT01241305
- Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated VasculitisTerminatedNCT05168475Phase 2Results posted
- Anti-neutrophil Cytoplasmic Antibody in Interstitial Lung Disease.CompletedNCT04413149Results posted
- A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated VasculitisCompletedNCT02994927Phase 3Results posted
- Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab DosingTerminatedNCT02749292Phase 4Results posted
- Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated VasculitisCompletedNCT02222155Phase 2Results posted
- Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated VasculitisCompletedNCT02169219Phase 4Results posted
- PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic DiseasesCompletedNCT02084147Not applicableResults posted
- The Assessment of Prednisone In Remission Trial - Centers of Excellence ApproachCompletedNCT01940094Phase 3Results posted
- Defining Immune Tolerance in ANCA-associated Vasculitis (AAV)TerminatedNCT01934504Results posted
- Rituximab Vasculitis Maintenance StudyCompletedNCT01697267Phase 3Results posted
- Belimumab in Remission of VASculitisCompletedNCT01663623Phase 3Results posted
- A Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With ANCA-Associated VasculitisCompletedNCT01363388Phase 2Results posted
- GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic DiseasesTerminatedNCT01257802Phase 3Results posted
- Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated VasculitisCompletedNCT00987389Phase 3Results posted
- Improving the Quality of Patient Care by Using a Clinical Expert System.CompletedNCT00430755Not applicableResults posted
- Hematopoietic Stem Cell Support in VasculitisTerminatedNCT00278512Phase 1Results posted
- Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic PolyangiitisCompletedNCT00104299Phase 2/3Results posted
- Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic VasculitisCompletedNCT00029107Phase 2Results posted
- Long-Term Safety and Effectiveness of Mepolizumab 300 mg in Europe (Mepo LTF Study)CompletedNCT07591753
- Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPAActive, not recruitingNCT06868290Phase 2
- Evaluation of Platelet Aggregability in Patients with Takayasu's ArteritisActive, not recruitingNCT06807788
- Six-months Versus Nine-months ATT for Ocular TBCompletedNCT06613919Phase 4
- Retrospective Analysis of Systemic Glucocorticoid Mediated Long-term Effects, Patient Pathways and Economic Burden Across Multiple IndicationsCompletedNCT06488703
- Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.Active, not recruitingNCT06321601Phase 3
- Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)Active, not recruitingNCT06294236Phase 1
- How Sirtuin Levels Change During Behçet DiseaseActive, not recruitingNCT06266247Not applicable
- Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With PolyangiitisActive, not recruitingNCT06230354Phase 2
- A Study to Assess the Mass Balance Recovery (Absorption, Distribution, Metabolism and Excretion) of [14C]CCX168 in Healthy ParticipantsCompletedNCT06004960Phase 1
- A Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential of CCX168 With Concomitant MedicationsCompletedNCT06004947Phase 1
- A Study in Healthy Volunteers to Evaluate the Pharmacokinetic Food Effect and Cardiac Safety of CCX168CompletedNCT05988021Phase 1
- A Study of CCX168 in Japanese and Caucasian Healthy Adult MalesCompletedNCT05988008Phase 1